Objective
to report the 3-year clinical outcomes of FFR-guided PCI compared to CABG for treatment of patients with 3-VD
Study
multicentre, randomised trial
Population
patients with 3-VD not involving left main coronary artery
Endpoints
3 incidents of composite of death, MI or stroke
Conclusion
the composite adverse event rate of death, MI or stroke at 3-years was not statistically different for treatment of 3-VD with FFR-guided PCI or CABG
Zimmerman et al. Circulation 2023:online August
